An Act to ensure access to generic medication
Massachusetts bill removes barriers to generic medication access to lower patient costs and increase affordable drug alternatives.
Massachusetts bill removes barriers to generic medication access to lower patient costs and increase affordable drug alternatives.
HD 2356 aims to expand access to generic medications in Massachusetts by removing or reducing barriers that currently limit their availability and affordability. The bill likely addresses insurance formulary restrictions, pharmacy benefit manager practices, or pricing mechanisms that disadvantage generic drug options. This represents an effort to increase cost savings for patients and the healthcare system by promoting use of chemically equivalent, lower-cost alternatives to brand-name drugs.
Generic medications cost significantly less than brand-name drugs while containing identical active ingredients, making them critical for affordability and equitable healthcare access. Many Massachusetts residents, particularly those with limited incomes, struggle with medication costs; expanding generic access could reduce out-of-pocket expenses and improve medication adherence. Increased generic utilization also reduces overall healthcare spending, potentially freeing resources for other medical needs.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.